Roles of USF, Ikaros and Sp proteins in the transcriptional regulation of the human reduced folate carrier B promoter

Biochemical Journal

Volumn 383, Issue 2, 2004, Pages 249-257

  Liu, Mingjun ^a   Whetstine, Johnathan R ^b,c   Payton, Scott G ^b   Ge, Yubin ^a   Flatley, Robin M ^a   Matherly, Larry H ^a,b  

^a KARMANOS CANCER INSTITUTE   (United States)

^b WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Chromatin; Ikaros; Methotrexate; Reduced folate carrier; Sp1; Upstream stimulatory factor (USF)

Indexed keywords

BIOASSAY; CELLS; IMMUNOLOGY; MUTAGENESIS; PRECIPITATION (CHEMICAL); TISSUE;

HUMAN REDUCED FOLATE CARRIER (HRFC); IMMUNOPRECIPITATION ASSAYS; REPORTER GENE ACTIVITY; TRANSACTIVATION;

PROTEINS;

HISTONE; HUMAN REDUCED FOLATE CARRIER; HUMAN REDUCED FOLATE CARRIER B; IKAROS 2 PROTEIN; IKAROS 8 PROTEIN; IKAROS RELATED PROTEIN; IKAROS TRANSCRIPTION FACTOR; METHOTREXATE; REDUCED FOLATE CARRIER; REPRESSOR PROTEIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR SP1; UNCLASSIFIED DRUG; UPSTREAM STIMULATORY FACTOR; UPSTREAM STIMULATORY FACTOR 1; UPSTREAM STIMULATORY FACTOR 2A;

ACETYLATION; ARTICLE; ASSAY; CELL STRAIN; CELL STRAIN HT1080; CHROMATIN; CHROMATIN IMMUNOPRECIPITATION; E BOX ELEMENT; GC BOX; GEL MOBILITY SHIFT ASSAY; GENE ACTIVITY; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENETIC TRANSFECTION; HOMEOBOX; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN FAMILY; PROTEIN PROTEIN INTERACTION; REPORTER GENE; TRANSACTIVATION; TRANSCRIPTION INITIATION SITE; TRANSCRIPTION REGULATION;

ACETYLATION; ANIMALS; BASE SEQUENCE; CELL LINE; CELL LINE, TUMOR; CHROMATIN IMMUNOPRECIPITATION; DNA-BINDING PROTEINS; DROSOPHILA MELANOGASTER; ELECTROPHORETIC MOBILITY SHIFT ASSAY; GENE EXPRESSION REGULATION; GENES, REPORTER; HISTONES; HUMANS; IKAROS TRANSCRIPTION FACTOR; MEMBRANE TRANSPORT PROTEINS; MOLECULAR SEQUENCE DATA; PROMOTER REGIONS (GENETICS); RESPONSE ELEMENTS; RNA, MESSENGER; SEQUENCE DELETION; SP1 TRANSCRIPTION FACTOR; TRANS-ACTIVATION (GENETICS); TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC; TRANSFECTION; UPSTREAM STIMULATORY FACTORS;

EID: 7444264527     PISSN: 02646021     EISSN: None     Source Type: Journal    
DOI: 10.1042/BJ20040414     Document Type: Article

References (39)

1. Stokstad, E. L. R. (1990) Historical perspective on key advances in the biochemistry and physiology of folates. In Folic Acid Metabolism in Health and Disease (Picciano, M. F., Stokstad, E. L. R. and Gregory, J. F., eds.), pp. 1-21, Wiley-Liss, New York
2. Jansen, G. (1999) Receptor- and carrier-mediated transport systems for folates and antifolates. Exploitation for folate chemotherapy and immunotherapy. In Anticancer Development Guide: Antifolate Drugs in Cancer Therapy (Jackman, A. L., ed.), pp. 293-321, Humana Press, Totowa, NJ
3. Matherly, L. H. and Goldman, I. D. (2003) Membrane transport of folates. Vitam. Horm. 66, 403-456
4. Goldman, I. D. and Zhao, R. (2002) Molecular, biochemical, and cellular pharmacology of pemetrexed. Semin. Oncol. 29, 3-17
5. Schuetz, J. D., Matherly, L. H., Westin, E. H. and Goldman, I. D. (1998) Evidence for a functional defect in the translocation of the methotrexate transport carrier in a methotrexate resistant murine L1210 leukemia cell line. J. Biol. Chem. 263, 9840-9847
6. Gong, M., Yess, J., Connolly, T., Ivy, S. P., Ohnuma, T., Cowan, K. H. and Moscow, J. A. (1997) Molecular mechanism of antifolate transport deficiency in a methotrexate resistant MOLT-3 human leukemia cell line. Blood 89, 2494-2499
7. Jansen, G., Mauritz, R., Drori, S., Sprecher, H., Kathman, I., Bunni, M., Priest, D. G., Noordhuis, P., Schornagel, J. H., Pinedo, H. M. et al. (1998) A structurally altered human reduced folate carrier with increased folic acid transport mediates a novel mechanism of antifolate resistance. J. Biol. Chem. 273, 30189-30198
8. Sirotnak, F. M., Moccio, D. M., Kelleher, L. E. and Goutas, L. J. (1981) Relative frequency and kinetic properties of transport-defective phenotypes among methotrexate resistant L1210 clonal cell lines derived in vivo. Cancer Res. 41, 4442-4452
9. Gorlick, R., Goker, E., Trippett, T, Steinherz, P., Elisseyeff, Y., Mazumdar, M., Flintoff, W. F. and Bertino, J. R. (1997) Defective transport is a common mechanism of acquired methotrexate resistance in acute lymphocytic leukemia and is associated with decreased reduced folate carrier expression. Blood 89, 1013-1018
10. Guo, W., Healey, J. H., Meyeers, P. A., Ladanyai, M., Huvos, A. G., Bertino, J. R. and Gorlick, R. (1999) Mechanisms of methotrexate resistance in osteosarcoma. Clin. Cancer Res. 5, 621-627
11. Zhang, L., Taub, J. W., Williamson, M. Wong, S. C., Hukku, B., Pullen, J., Ravindranath, Y. and Matherly, L. H. (1998) Reduced folate carrier gene expression in childhood acute lymphoblastic leukemia: relationship to immunophenotype and ploidy. Clin. Cancer Res. 4, 2169-2177
12. Zhang, L., Wong, S. C. and Matherly, L. H. (1998) Transcript heterogeneity of the human reduced folate carrier results from the use of multiple promoters and variable splicing of alternative upstream exons. Biochem. J. 332, 773-780
13. Tolner, B., Roy, K. and Sirotnak, F. M. (1998) Structural analysis of the human RFC-1 gene encoding a folate transporter reveals multiple promoters and alternatively spliced transcripts with 5′ end heterogeneity. Gene 211, 331-341
14. Whetstine, J. R. and Matherly, L. H. (2001) The basal promoters for the human reduced folate carrier gene are regulated by a GC-box and a cAMP-response element/AP-1-like element. J. Biol. Chem. 276, 6350-6358
15. Whetstine, J. R., Flatley, R. M. and Matherly, L. H. (2002) The human reduced folate carrier gene is ubiquitously and differently expressed in normal human tissues: identification of seven non-coding exons and characterization of a novel promoter. Biochem. J. 367, 629-640
16. Flatley, R. M., Payton, S. G., Taub, J. W. and Matherly, L. H. (2004) Primary acute lymphoblastic leukemia cells use a novel promoter and 5′ non-coding exon for the human reduced folate carrier that encodes a modified carrier translated from an upstream translational start. Clin. Cancer Res. 10, 5111-5122
17. Whetstine, J. R., Witt, T. L. and Matherly, L. H. (2002) The human reduced folate carrier gene is regulated by the AP2 and sp1 transcription factor families and a functional 61-base pair polymorphism. J. Biol. Chem. 277, 43873-43880
18. Horton, R. M., Cai, Z. L., Ho, S. N. and Pease, L. R. (1990) Gene splicing by overlap extension: tailor-made genes using the polymerase chain reaction. Biotechniques 8, 528-535
19. Molnar, A. and Georgopoulos, K. (1994) The Ikaros gene encodes a family of functionally diverse zinc finger DNA-binding proteins. Mol. Cell. Biol. 14, 8292-8303
20. Ge, Y., Jensen, T., Matherly, L. H. and Taub, J. W. (2003) Physical and functional interactions between USF and Sp1 proteins regulated human deoxycytidine kinase activity. J. Biol. Chem. 278, 49901-49910
21. Ge, Y., Jensen, T. L., Matherly, L. H. and Taub, J. W. (2003) Transcriptional regulation of human cystathionine beta synthase gene expression in Down syndrome and non-Down syndrome megakaryocytic leukemia cell lines. Blood 101, 1551-1557
22. Suske, G. (1999) The Sp-family of transcription factors. Gene 238, 291-300
23. Henrion, A. A., Martinez, A., Mattei, M. G., Kahn, A. and Raymondjean, M. (1995) Structure, sequence, and chromosomal location of the gene for USF2 transcription factors in mouse. Genomics 25, 36-43
24. Grandori, C., Cowley, S. M., James, L. P. and Eisenman, R. N. (2000) The Myc/Max/Mad network and the transcriptional control of cell behavior. Annu. Rev. Cell Dev. Biol. 16, 653-699
25. Gregor, P. D., Sawadogo, M. and Roeder, R. G. (1990) The adenovirus major late transcription factor USF is a member of the helix-loop-helix group of regulatory proteins and binds to DNA as a dimer. Genes Dev. 4, 1730-1740
26. Morgan, B., Sun, L., Avitahl, N., Andrikopoulos, K., Gonzales, E., Nichogiannopoulou, A., Wu, P., Neben, S. and Georgopoulos, K. (1997) Aiolos, a lymphoid restricted transcription factor that interacts with Ikaros to regulate lymphocyte differentiation. EMBO J. 16, 2004-2013
27. Hahm, K., Cobb, B. S., McCarty, A. S., Brown, K. E., Klug, C. A., Lee, R., Akashi, K., Weissman, I. L., Fisher, A. G. and Smale, S. T. (1998) Helios, a T cell-restricted Ikaros family member that quantitatively associates with Ikaros at centromeric heterochromatin. Genes Dev. 12, 782-796
28. Kelley, C. M., Ikeda, T., Koipally, J., Avitahl, N., Georgopoulos, K. and Morgan, B. A. (1998) Helios, a novel dimerization partner of Ikaros expressed in the earliest hematopoietic progenitors. Curr. Biol. 8, 508-515
29. Sun, L., Liu, A. and Georgopoulos, K. (1996) Zinc finger-mediated protein interactions modulate Ikaros activity, a molecular control of lymphocyte development. EMBO J. 15, 5358-5369
30. Moore, A. W., Barbel, S., Jan, L. Y. and Jan, Y. N. (2000) A genomewide survey of basic helix-loop-helix factors in Drosophila. Proc. Natl. Acad. Sci. U.S.A. 97, 10436-10441
31. Kim, J., Sif, S., Jones, B., Jackson, A., Koipally, J., Heller, E., Winandy, S., Viel, A., Sawyer, A., Ikeda, T. et al. (1999) Ikaros DNA-binding proteins direct formation of chromatin remodeling complexes in lymphocytes. Immunity 10, 345-355
32. Koipally, J., Renold, A., Kim, J. and Georgopoulos, K. (1999) Repression by Ikaros and Aiolos is mediated through histone deacetylase complexes. EMBO J. 18, 3090-3100
33. Li, N. and Seetharam, B. (1998) A 69-base pair fragment derived from human transcobalamin II promoter is sufficient for high bi-directional activity in the absence of a TATA box and an initiator element in the transfected cells. J. Biol. Chem. 272, 28171-28177
34. Ge, Y., Konrad, M. A., Matherly, L. H. and Taub, J. W. (2001) Transcriptional regulation of the human cystathionine-β-synthase-1b basal promoter: synergistic transactivation by transcription factors NF-Y and Sp1/Sp3. Biochem. J. 357, 97-105
35. Winandy, S., Wu, P. and Georgopoulos, K. (1995) A dominant mutation in the Ikaros gene leads to rapid development of leukemia and lymphoma. Cell (Cambridge, Mass.) 83, 289-299
36. Sun, L., Crotty, M. L., Sensel, M., Sather, H., Navara, C., Nachman, J., Steinherz, P. G., Gaynon, P. S., Seibel, N., Mao, C. et al. (1999) Expression of dominant-negative Ikaros isoforms in T-cell acute lymphoblastic leukemia. Clin. Cancer Res. 5, 2112-2120
37. Sun, L., Goodman, P. A., Wood, C. M., Crotty, M. L., Sensel, M., Sather, H., Navara, C., Nachman, J., Steinherz, P. G. et al. (1999) Expression of aberrantly 35 spliced oncogenic ikaros isoforms in childhood acute lymphoblastic leukemia. J. Clin. Oncol. 17, 3753-3766
38. Koipally, J. and Georgopoulos, K. (2000) Ikaros interactions with CtBP reveal a repression mechanism that is independent of histone deacetylase activity. J. Biol. Chem. 275, 19594-19602
39. Worm, J., Kirkin, A. F., Dzhandzhugazyan, K. N. and Guldberg, P. (2001) Methylation-dependent silencing of the reduced folate carrier gene in inherently methotrexate-resistant human breast cancer cells. J. Biol. Chem. 276, 39990-40000